These three genes could reduce the number of T-cell CD4 naive and T-cell CD4 memory resting in SSc-PAH PBMCs through the regulation of T-cell activation, which suggest that these three molecules may be involved in the development of SSc-PAH. This evidence concerns the gene CD4 and pulmonary arterial hypertension.